ArtBio
artbio.com
Actively hiring
Oncology Therapeutics
Prescription Drugs
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$222M
2 rounds on record
Latest round
$132M
Series B · Jul 2025 · 13 mo ago
Team
17
US Form 5500 (plan participants) · Dec 2024
Hiring now
1
+1 posted in 30 days
Backers
1
F-Prime Capital
The money's age
Due for its next round
13 months since the last round · and hiring
Momentum
13/100
hiring for its size
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 9, 2025
Certified ARTBIO Announces FDA Clearance of IND Application for Lead Alpha Radioligand Therapy AB001 · PRNewswire
Jul 29, 2025
Raised a round Series B $132M · led by Sofinnova Investments · PRNewswire
Jan 9, 2024
Partnership SpectronRx and ARTBIO Join Forces to Develop and Manufacture Clinical Supply of Novel Alpha Radioligand Therapy AB001 for Indiana and Surrounding Sta… · businesswire.com
Dec 7, 2023
Raised a round Venture round $90M · YahooFinance
2021
Founded
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Jul 2025 | $132M | Sofinnova Investments lead, B Capital lead, Omega Funds | PRNewswire |
| Venture round | Dec 2023 | $90M | — | YahooFinance |
Backed byfrom the funds' portfolios and accelerator catalogs
F-Prime Capital Similar startupsby what they do, their industry and backers
Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
Targeting the Tumor Ecosystem to address cancer drug resistance and improve patients’ lives.
Learn how Dispatch Biotherapeutics is expanding the curative potential of immunotherapies by dispatching its Flare platform to overcome…
CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in…
Pharmanovia, the lifecycle management company, is committed to realising the full potential of established medicines.
News
ARTBIO Announces FDA Clearance of IND Application for Lead Alpha Radioligand Therapy AB001
/PRNewswire/ -- ARTBIO, Inc. ("ARTBIO"), a clinical-stage radiopharmaceutical company developing a new class of Pb212 alpha radioligand therapies (ARTs), today...
Read more
Report
ARTBIO: $132 Million Series B Raised For New Class Of Alpha Radioligand Therapies
ARTBIO, a clinical-stage radiopharmaceutical company, is focused on developing alpha radioligand therapies (ARTs) for various types of cancer. The company has secured $132 million in Series B financing, co-led by new investors Sofinnova Investments and B
Read more
Report
ARTBIO Appoints Four New Board Members, Co-Founder Transitions to Technical Advisory Board Role
Read more
Report
ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure
Financing co-led by new investors Sofinnova Investments and B Capital, along with an existing investor with continued support from F-Prime, Omega Funds, and...
Read more
Report
Pro access
Upgrade to see all 11 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Growth
Hiring Momentum
48/100
Stable
Open positions
1
1 opened / 1 closed in 30 days
Median time-to-fill
71 days
faster than 21% of the market
ATS activity
Every ~10 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Administrative
50% ▼
Public Policy
50% ▲
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Cambridge
Cambridge
United States
HQ
Locations
1 open roles 1 posted in 90 days 100% remote 50-200 est. staff
hires for Public Policy
One Kendall Sq, B200, Suite 001, Cambridge, MA 02139
Earlier presence
Oslo, Norway